DK336987D0 - Immobiliseringsmetode - Google Patents

Immobiliseringsmetode

Info

Publication number
DK336987D0
DK336987D0 DK336987A DK336987A DK336987D0 DK 336987 D0 DK336987 D0 DK 336987D0 DK 336987 A DK336987 A DK 336987A DK 336987 A DK336987 A DK 336987A DK 336987 D0 DK336987 D0 DK 336987D0
Authority
DK
Denmark
Prior art keywords
immobilization
polyazetidine
coenzymes
dewatering
antibodies
Prior art date
Application number
DK336987A
Other languages
English (en)
Inventor
Henrik Moellgaard
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Priority to DK336987A priority Critical patent/DK336987D0/da
Publication of DK336987D0 publication Critical patent/DK336987D0/da
Priority to ES88306038T priority patent/ES2061656T3/es
Priority to AT88306038T priority patent/ATE98689T1/de
Priority to DE88306038T priority patent/DE3886280T2/de
Priority to EP88306038A priority patent/EP0297912B1/en
Priority to JP63505497A priority patent/JP2641934B2/ja
Priority to KR1019890700356A priority patent/KR970000186B1/ko
Priority to PCT/DK1988/000108 priority patent/WO1989000195A1/en
Priority to DK097189A priority patent/DK160843C/da
Priority to US07/512,823 priority patent/USRE33441E/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/091—Phenol resins; Amino resins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/098—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer formed in the presence of the enzymes or microbial cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C12N9/92—Glucose isomerase (5.3.1.5; 5.3.1.9; 5.3.1.18)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DK336987A 1985-06-14 1987-07-01 Immobiliseringsmetode DK336987D0 (da)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DK336987A DK336987D0 (da) 1987-07-01 1987-07-01 Immobiliseringsmetode
ES88306038T ES2061656T3 (es) 1987-07-01 1988-06-30 Procedimiento de inmovilizacion.
AT88306038T ATE98689T1 (de) 1987-07-01 1988-06-30 Immobilisierungsverfahren.
DE88306038T DE3886280T2 (de) 1987-07-01 1988-06-30 Immobilisierungsverfahren.
EP88306038A EP0297912B1 (en) 1987-07-01 1988-06-30 Process for immobilization
JP63505497A JP2641934B2 (ja) 1987-07-01 1988-07-01 固定化方法
KR1019890700356A KR970000186B1 (ko) 1987-07-01 1988-07-01 폴리아제티딘과의 교차결합에 의한 생물학적 물질의 고정방법
PCT/DK1988/000108 WO1989000195A1 (en) 1987-07-01 1988-07-01 Process for immobilization of biological material by cross-linking with polyazetidine
DK097189A DK160843C (da) 1987-07-01 1989-03-01 Fremgangsmaade til fremstilling af et partikelformet, immobiliseret produkt og anvendelse af immobiliseret enzym fremstillet herved
US07/512,823 USRE33441E (en) 1985-06-14 1990-04-23 Immobilization of biologically active material with glutaraldehyde and polyazaetidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK336987A DK336987D0 (da) 1987-07-01 1987-07-01 Immobiliseringsmetode

Publications (1)

Publication Number Publication Date
DK336987D0 true DK336987D0 (da) 1987-07-01

Family

ID=8122094

Family Applications (2)

Application Number Title Priority Date Filing Date
DK336987A DK336987D0 (da) 1985-06-14 1987-07-01 Immobiliseringsmetode
DK097189A DK160843C (da) 1987-07-01 1989-03-01 Fremgangsmaade til fremstilling af et partikelformet, immobiliseret produkt og anvendelse af immobiliseret enzym fremstillet herved

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK097189A DK160843C (da) 1987-07-01 1989-03-01 Fremgangsmaade til fremstilling af et partikelformet, immobiliseret produkt og anvendelse af immobiliseret enzym fremstillet herved

Country Status (8)

Country Link
EP (1) EP0297912B1 (da)
JP (1) JP2641934B2 (da)
KR (1) KR970000186B1 (da)
AT (1) ATE98689T1 (da)
DE (1) DE3886280T2 (da)
DK (2) DK336987D0 (da)
ES (1) ES2061656T3 (da)
WO (1) WO1989000195A1 (da)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI85384C (fi) * 1989-09-06 1992-04-10 Cultor Oy Foerfarande foer hydrolysering av hemicellulosa med immobiliserade enzymer och produkt som omfattar ett immobiliserat hemicellulolytiskt enzym.
DK589389D0 (da) * 1989-11-23 1989-11-23 Novo Nordisk As Immobiliseret enzympraeparat
AT401653B (de) * 1994-10-05 1996-11-25 Avl Verbrennungskraft Messtech Verfahren zur immobilisierung biologischer komponenten in einer polymermatrix sowie biosensoren unter verwendung derartiger immobilisate
US6060268A (en) * 1995-07-18 2000-05-09 Gist-Brocades B.V. Penicillin G acylase immobilized with a crosslinked mixture of gelled gelatin and amino polymer
EP0839192B1 (en) * 1995-07-18 2008-12-10 DSM IP Assets B.V. An improved immobilized penicillin g acylase
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
DK1960430T3 (da) 2005-12-09 2015-01-05 Ucb Pharma Sa Antistofmolekyler der har specificitet for humant il-6
GB0620729D0 (en) 2006-10-18 2006-11-29 Ucb Sa Biological products
GB0807413D0 (en) 2008-04-23 2008-05-28 Ucb Pharma Sa Biological products
LT2398498T (lt) 2009-02-17 2019-01-10 Ucb Biopharma Sprl Antikūno molekulės, pasižyminčios specifiškumu žmogaus ox40
GB0904214D0 (en) 2009-03-11 2009-04-22 Ucb Pharma Sa Biological products
EP2475682B1 (en) 2009-09-10 2018-01-31 UCB Biopharma SPRL Multivalent antibodies
GB0920127D0 (en) 2009-11-17 2009-12-30 Ucb Pharma Sa Antibodies
GB0920324D0 (en) 2009-11-19 2010-01-06 Ucb Pharma Sa Antibodies
GB201000467D0 (en) 2010-01-12 2010-02-24 Ucb Pharma Sa Antibodies
TW201134488A (en) 2010-03-11 2011-10-16 Ucb Pharma Sa PD-1 antibodies
JP5920929B2 (ja) 2010-03-11 2016-05-18 ユセベ ファルマ ソシエテ アノニム Ｐｄ−１抗体
GB201005064D0 (en) 2010-03-25 2010-05-12 Ucb Pharma Sa Biological products
ES2717883T3 (es) 2010-03-25 2019-06-26 Ucb Biopharma Sprl Moléculas de DVD-LG estabilizadas con disulfuro
GB201014033D0 (en) 2010-08-20 2010-10-06 Ucb Pharma Sa Biological products
BR112013017951B1 (pt) 2011-01-14 2022-09-27 UCB Biopharma SRL Anticorpo de neutralização, sequência de dna isolada, vetor de clonagem ou expressão, processo para a produção do anticorpo, composição farmacêutica, uso de anticorpo e uso da composição farmacêutica
MX2014002769A (es) 2011-09-16 2014-06-11 Ucb Pharma Sa Anticuerpos neutralizantes para las exotoxinas principales tcda y tcdb de clostridium difficile.
UA112203C2 (uk) 2011-11-11 2016-08-10 Юсб Фарма С.А. Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини
GB201203051D0 (en) 2012-02-22 2012-04-04 Ucb Pharma Sa Biological products
GB201203071D0 (en) 2012-02-22 2012-04-04 Ucb Pharma Sa Biological products
GB201208370D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Antibodies
CN102758289A (zh) * 2012-08-06 2012-10-31 天津工业大学 一种用于细胞固定化的机织物载体及其制备方法
GB201223276D0 (en) 2012-12-21 2013-02-06 Ucb Pharma Sa Antibodies and methods of producing same
GB201315487D0 (en) 2013-08-30 2013-10-16 Ucb Pharma Sa Antibodies
GB201320066D0 (en) 2013-11-13 2013-12-25 Ucb Pharma Sa Biological products
GB201409558D0 (en) 2014-05-29 2014-07-16 Ucb Biopharma Sprl Method
GB201411320D0 (en) 2014-06-25 2014-08-06 Ucb Biopharma Sprl Antibody construct
GB201412658D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201412659D0 (en) 2014-07-16 2014-08-27 Ucb Biopharma Sprl Molecules
GB201506870D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method
GB201506869D0 (en) 2015-04-22 2015-06-03 Ucb Biopharma Sprl Method
TW201702271A (zh) 2015-04-30 2017-01-16 哈佛大學校長及研究員協會 治療代謝病症之抗－ａｐ２抗體及抗原結合劑
GB201508180D0 (en) 2015-05-13 2015-06-24 Ucb Biopharma Sprl Antibodies
EA039951B1 (ru) 2015-05-27 2022-03-31 Юсб Биофарма Спрл Ингибитор активности csf-1r, предназначенный для лечения или профилактики эпилепсии или болезни паркинсона, и фармацевтическая композиция на его основе
US10287343B2 (en) 2015-07-06 2019-05-14 Ucb Biopharma Sprl Tau-binding antibodies
GB201601077D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibody molecule
GB201601073D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies
GB201601075D0 (en) 2016-01-20 2016-03-02 Ucb Biopharma Sprl Antibodies molecules
CN108350068A (zh) 2015-10-27 2018-07-31 Ucb生物制药私人有限公司 使用抗-il-17a/f抗体的治疗方法
GB201521389D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Method
GB201521383D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl And Ucb Celltech Method
GB201521393D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521382D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201521391D0 (en) 2015-12-03 2016-01-20 Ucb Biopharma Sprl Antibodies
GB201522394D0 (en) 2015-12-18 2016-02-03 Ucb Biopharma Sprl Antibodies
US11534496B2 (en) 2016-06-07 2022-12-27 The Brigham And Women's Hospital, Inc. Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions
GB201610198D0 (en) 2016-06-10 2016-07-27 Ucb Biopharma Sprl Anti-ige antibodies
WO2018038684A1 (en) 2016-08-26 2018-03-01 Agency For Science, Technology And Research Macrophage stimulating protein receptor (or ron - recepteur d' origine nantais) antibodies and uses thereof
GB201616596D0 (en) 2016-09-29 2016-11-16 Nascient Limited Epitope and antibodies
GB201621635D0 (en) 2016-12-19 2017-02-01 Ucb Biopharma Sprl Crystal structure
WO2018183366A1 (en) 2017-03-28 2018-10-04 Syndax Pharmaceuticals, Inc. Combination therapies of csf-1r or csf-1 antibodies and a t-cell engaging therapy
KR20240042244A (ko) 2017-05-19 2024-04-01 신닥스 파마슈티컬스, 인크. 조합 요법
GB201802486D0 (en) 2018-02-15 2018-04-04 Ucb Biopharma Sprl Methods
JP7369705B2 (ja) * 2018-09-18 2023-10-26 株式会社カネカ 固定化微生物の製造方法及びそれを用いたアミノ酸の製造方法
CA3116091A1 (en) 2018-10-16 2020-04-23 UCB Biopharma SRL Method for the treatment of myasthenia gravis
US20210277131A1 (en) 2019-03-26 2021-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT EMPLOYING ANTI-IL-l3R ANTIBODY OR BINDING FRAGMENT THEREOF
GB201919062D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Antibody
GB201919058D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Multi-specific antibodies
GB201919061D0 (en) 2019-12-20 2020-02-05 Ucb Biopharma Sprl Multi-specific antibody
GB202001447D0 (en) 2020-02-03 2020-03-18 Ucb Biopharma Sprl Antibodies
EP4229086A1 (en) 2020-10-15 2023-08-23 UCB Biopharma SRL Binding molecules that multimerise cd45
JP2023550596A (ja) 2020-11-02 2023-12-04 ユーシービー バイオファルマ エスアールエル 運動ニューロン神経変性障害の治療のための抗ｔｒｅｍ１中和抗体の使用
MX2023006650A (es) 2020-12-07 2023-06-21 UCB Biopharma SRL Anticuerpos multiespecificos y combinaciones de anticuerpos.
BR112023008265A2 (pt) 2020-12-07 2024-02-06 UCB Biopharma SRL Anticorpos contra interleucina-22
WO2022186772A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2022186773A1 (en) 2021-03-01 2022-09-09 Aslan Pharmaceuticals Pte Ltd TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
EP4067381A1 (en) 2021-04-01 2022-10-05 Julius-Maximilians-Universität Würzburg Novel tnfr2 binding molecules
AU2022268545A1 (en) 2021-05-03 2023-11-02 UCB Biopharma SRL Antibodies
GB202111905D0 (en) 2021-08-19 2021-10-06 UCB Biopharma SRL Antibodies
WO2023048650A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Rα1 ANTIBODY OR BINDING FRAGMENT THEREOF
WO2023048651A1 (en) 2021-09-27 2023-03-30 Aslan Pharmaceuticals Pte Ltd Method for treatment of moderate to severe atoptic dematitis
GB202115122D0 (en) 2021-10-21 2021-12-08 Dualyx Nv Binding molecules targeting IL-2 receptor
TW202333784A (zh) 2021-10-29 2023-09-01 新加坡商亞獅康私人有限公司 抗ｉｌ１３ｒ抗體調配物
WO2023140780A1 (en) 2022-01-24 2023-07-27 Aslan Pharmaceuticals Pte Ltd. Method of treating inflammatory disease
TW202337905A (zh) 2022-02-23 2023-10-01 新加坡商亞獅康私人有限公司 抗il13r抗體之糖基化形式
GB202210679D0 (en) 2022-07-21 2022-09-07 Dualyx Nv Binding molecules targeting il-12rb2
WO2024043837A1 (en) 2022-08-26 2024-02-29 Aslan Pharmaceuticals Pte Ltd High concentration anti-il13r antibody formulation
WO2024054157A1 (en) 2022-09-06 2024-03-14 Aslan Pharmaceuticals Pte Ltd Treatment for sleep loss or sleep disturbance in patients with dermatitis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925157A (en) * 1972-07-12 1975-12-09 Pfizer Immobilized enzymes
GB1400468A (en) * 1972-07-22 1975-07-16 Beecham Group Ltd Enzyme preparation and use thereof
US4732851A (en) * 1982-03-16 1988-03-22 Purification Engineering, Inc. Immobilization of cells with a polyazetidine prepolymer
US4436813A (en) * 1982-03-16 1984-03-13 Purification Engineering, Inc. Immobilized microbial cell composition for making L-aspartic acid
DK152764C (da) * 1985-06-14 1988-10-03 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt

Also Published As

Publication number Publication date
DK97189A (da) 1989-03-01
ATE98689T1 (de) 1994-01-15
ES2061656T3 (es) 1994-12-16
DE3886280D1 (de) 1994-01-27
DE3886280T2 (de) 1994-03-31
DK160843B (da) 1991-04-22
EP0297912B1 (en) 1993-12-15
KR970000186B1 (ko) 1997-01-06
EP0297912A3 (en) 1990-01-10
DK160843C (da) 1991-10-14
JP2641934B2 (ja) 1997-08-20
EP0297912A2 (en) 1989-01-04
JPH01503677A (ja) 1989-12-14
KR890701737A (ko) 1989-12-21
WO1989000195A1 (en) 1989-01-12
DK97189D0 (da) 1989-03-01

Similar Documents

Publication Publication Date Title
DK97189D0 (da) Immobiliseringsproces
DE3884016T2 (de) Enzym-Immobilisierung und Bioaffinitätstrennungen mit Perfluorcarbon-Polymer-Trägern.
KR870700647A (ko) 디엔계중합체와 그 제조방법 및 이를 함유하는 고무 조성물
DE68922216T2 (de) Zellenzuchtverfahren in bioreaktoren.
EP0138833A4 (en) Methods for determining the viability of cells and device for their implementation.
IT8821481A0 (it) Processo ed apparato per la devolatilizzazione di soluzioni di polimeri.
DE3580031D1 (de) Eingekapselte polymerteilchen und deren herstellungsverfahren.
ATA326483A (de) Glaskuegelchen mit modifizierter oberflaeche, verfahren zu deren herstellung und verwendung derselben
HU9300275D0 (en) Method for binding emzyme in shape of crystal of spatial network structure
PL267910A1 (en) Constant catalyst applied for stereospecific polymerization of alfa-olefins,the method of its manufacture and the method of alfa-olefins polymerization in the presence of that catalyst
DE3382425D1 (de) Immobilisierte mikrobenzellen und verfahren zu deren herstellung und deren anwendung.
ZA849758B (en) Process for preparing oxirane-bearing polymer carriers for immobilizing enzymes and other materials bearing active hydrogen,and oxirane-bearing polymer carriers
DE3779905D1 (de) Zellkulturtraeger.
GB2151636B (en) Reactive polymer, method for manufacture thereof and use thereof
DE3782534T2 (de) Pechbasierte kohlenstoffasern mit hohem elastizitaetsmodul und verfahren zu deren herstellung.
DE3362885D1 (en) Polymerizable, optically active polymer and process for preparing polymerizable polymer
IL70840A (en) Cell culture apparatus,immobilized cell composite and process for preparation of the composite
GR3009564T3 (da)
IT8720302A0 (it) Dispositivo e procedimento per trattare materiale granulare, in particolare grano.
EP0137205A3 (en) Process for producing particulate polymer
ES2059479T3 (es) Procedimiento para preparar pregneno-oxazolinas.
DE3271040D1 (en) Carrier-fixed proteases and their use in biotechnology
AU2989989A (en) Cell culture apparatus and process using an immobilized cell composite
IE811808L (en) Immobilisation of globular microbial cells
EP0247881A3 (en) Process for culturing animal cells and appropriate media